Overview

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2027-03-30

Target enrollment:

Participant gender:

Summary

This study will be conducted to determine the clinical efficacy of axatilimab in Japanese participants with chronic graft-versus-host disease (cGVHD).

Phase:

PHASE3

Details

Lead Sponsor:

Incyte Biosciences Japan GK

Treatments:

axatilimab